RxDoctor Payments Data

Animesh Rathore, MD

Vascular Surgery · Norfolk, VANPI 1174758494

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (37.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Medtronic at 50.8% of the total. 2025 is the largest year on record at $28,603, 3.1 times the $9,294 reported in 2019. Among vascular surgery clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$82,930in general payments, 2019–2025

Across 545 payments — averaging $152.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$42K
  • W. L. Gore & Associates, Inc.$19K
  • Cook Medical LLC$4K
  • Abbott$3K
  • Philips North America LLC$3K
  • Penumbra, Inc.$2K
  • plus $11K from 26 others
$46,011in research payments, 2019–2025

Across 10 payments — averaging $4601.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Shape Memory Medical Inc.$42K
  • W. L. Gore & Associates, Inc.$4K

What the payments were for

  • Consulting fees$13,69517%
  • Speaking & faculty fees$18,21022%
  • Travel & lodging$19,91424%
  • Food & beverage$31,04737%
  • Education$650%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$82,930 in reported general payments places this provider in the 90th percentile of 143 vascular surgery providers in Virginia.

See all vascular surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$369,288
Medicare patients
908
Services billed
2,005

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban26$26,907
EliquisApixaban14$11,822
Prasugrel Hcl15$392
Atorvastatin Calcium48$266
ClopidogrelClopidogrel Bisulfate38$246
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$34

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →